Evidence map›Paper›PMID 32563999›Full record

ReviewPostgraduate medical journal2020

Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19).

Srikanth Umakanthan, Pradeep Sahu, Anu V Ranade, Maryann M Bukelo, Joseph Sushil Rao, Lucas Faria Abrahao-Machado, Samarika Dahal, Hari Kumar, Dhananjaya Kv

Open access · hybridFull text readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Postgraduate medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 334 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
334citing papers in PubMed, 7 pooled it
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

334 citing papers in PubMed, 7 syntheses or guidelines pooled it, 711 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

274 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 5 countries.

Srikanth UmakanthanParaclinical Sciences, The University of the West Indies at Saint Augustine Faculty of Medical Sciences, Saint Augustine, Trinidad and Tobago Srikanth.Umakanthan@sta.uwi.edu dr.u.srikanth@gmail.com.ORCID http://orcid.org/0000-0002-6713-2265
Pradeep SahuCentre for Medical Sciences Education, The University of the West Indies at Saint Augustine, Saint Augustine, Trinidad and Tobago.
Anu V RanadeBasic Medical Sciences, University of Sharjah, Sharjah, United Arab Emirates.
Maryann M BukeloDepartment of Anatomical Pathology, North Central Regional Health Authority, Eric Williams Medical Sciences Complex, Mount Hope, Trinidad and Tobago.
Joseph Sushil RaoDepartment of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
Lucas Faria Abrahao-MachadoDepartment of Pathology, Bacchi Laboratory, Sao Paulo, Brazil.
Samarika DahalDepartment of Oral Pathology, Institute of Medicine, Kathmandu, Nepal.
Hari KumarDepartment of International Public Health and Disease Surveillance, Midwest, Australia.
Dhananjaya KvDepartment of Radiology, Indiragandhi Institute of Child Health, Bangalore, India.
University of the West Indies · TTIndira Gandhi Institute of Child Health · INLaboratório Bacchi · BRUniversity of Minnesota · USUniversity of Sharjah · AE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus has emerged as a global health threat due to its accelerated geographic spread over the last two decades. This article reviews the current state of knowledge concerning the origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Historically, it has caused two pandemics: severe acute respiratory syndrome and Middle East respiratory syndrome followed by the present COVID-19 that emerged from China. The virus is believed to be acquired from zoonotic source and spreads through direct and contact transmission. The symptomatic phase manifests with fever, cough and myalgia to severe respiratory failure. The diagnosis is confirmed using reverse transcriptase PCR. Management of COVID-19 is mainly by supportive therapy along with mechanical ventilation in severe cases. Preventive strategies form the major role in reducing the public spread of virus along with successful disease isolation and community containment. Development of a vaccine to eliminate the virus from the host still remains an ongoing challenge.

Indexed as

COVID-19COVID-19 Drug TreatmentAntiviral AgentsCoronavirusCOVID-19 Nucleic Acid TestingCOVID-19 VaccinesDisease ManagementExtracorporeal Membrane OxygenationHumansLungMiddle East Respiratory Syndrome CoronavirusSARS-CoV-2Severe acute respiratory syndrome-related coronavirusTomography, X-Ray ComputedAntiviral AgentsCOVID-19 VaccinesBasic sciencesEducation and training (see medical education & training)Hepatobiliary surgeryHistopathologyMedical education and trainingPathologySurgeryTransplant surgery

Identifiers

PMID32563999
PMCPMC10016932
OpenAlexW3036718221

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read6
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.